Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 59,293 shares, an increase of 584.4% from the May 31st total of 8,663 shares. Based on an average daily volume of 412,091 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy”.

Fresenius SE & Co. Stock Performance

Shares of FSNUY stock opened at $11.41 on Friday. The company has a 50 day moving average price of $11.51 and a 200-day moving average price of $13.16. Fresenius SE & Co. has a 52 week low of $10.33 and a 52 week high of $33.93. The firm has a market capitalization of $25.71 billion, a PE ratio of 15.21 and a beta of 0.64. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The company had revenue of $6.75 billion for the quarter, compared to analysts’ expectations of $6.79 billion. As a group, equities research analysts expect that Fresenius SE & Co. will post 1.03 earnings per share for the current year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.